ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Chronic Heart Failure Treatment Market Research Report 2025
Published Date: June 2025
|
Report Code: QYRE-Auto-16A5863
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Chronic Heart Failure Treatment Market Insights Forecast to 2028
BUY CHAPTERS

Global Chronic Heart Failure Treatment Market Research Report 2025

Code: QYRE-Auto-16A5863
Report
June 2025
Pages:99
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Medtronic Inc
Abbott
Johnson & Johnson
Merck
Stanley Pharmaceuticals
New Haven Pharmaceuticals, Inc.
Boston Scientific Corporation
HeartWare
Pfizer Inc
GlaxoSmithKline PLC
Novartis International AG
Biovail Corporation
Bristol Myers Squibb Company
Abiomed Inc
Symplmed Pharmaceuticals
Berlin Heart GmbH
ReliantHeart Inc
Cardiokinetix
Biotronik AG
Jarvik Heart

Chronic Heart Failure Treatment Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Chronic Heart Failure Treatment Market

Chronic Heart Failure Treatment Market

The global market for Chronic Heart Failure Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Chronic Heart Failure Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Heart Failure Treatment.
The Chronic Heart Failure Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Chronic Heart Failure Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chronic Heart Failure Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Chronic Heart Failure Treatment Market Report

Report Metric Details
Report Name Chronic Heart Failure Treatment Market
CAGR 5%
Segment by Type
Segment by Application
  • Hospital
  • Clinic
  • Household
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Medtronic, Abbott, Johnson & Johnson, Merck, Stanley Pharmaceuticals, New Haven Pharmaceuticals, Inc., Boston Scientific Corporation, HeartWare, Pfizer, GlaxoSmithKline plc, Novartis International AG, Biovail Corporation, Bristol-Myers Squibb Company, Abiomed, Symplmed Pharmaceuticals, Berlin Heart GmbH, ReliantHeart, Inc., Cardiokinetix, Biotronik, Jarvik Heart
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Chronic Heart Failure Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Chronic Heart Failure Treatment Market report?

Ans: The main players in the Chronic Heart Failure Treatment Market are Medtronic, Abbott, Johnson & Johnson, Merck, Stanley Pharmaceuticals, New Haven Pharmaceuticals, Inc., Boston Scientific Corporation, HeartWare, Pfizer, GlaxoSmithKline plc, Novartis International AG, Biovail Corporation, Bristol-Myers Squibb Company, Abiomed, Symplmed Pharmaceuticals, Berlin Heart GmbH, ReliantHeart, Inc., Cardiokinetix, Biotronik, Jarvik Heart

What are the Application segmentation covered in the Chronic Heart Failure Treatment Market report?

Ans: The Applications covered in the Chronic Heart Failure Treatment Market report are Hospital, Clinic, Household, Others

What are the Type segmentation covered in the Chronic Heart Failure Treatment Market report?

Ans: The Types covered in the Chronic Heart Failure Treatment Market report are ICDs, VADs, Drugs, Others

Recommended Reports

Cardiovascular Treatments

Chronic Disease Drugs

Advanced Cardiac Devices

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chronic Heart Failure Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 ICDs
1.2.3 VADs
1.2.4 Drugs
1.2.5 Others
1.3 Market by Application
1.3.1 Global Chronic Heart Failure Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Household
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Chronic Heart Failure Treatment Market Perspective (2020-2031)
2.2 Global Chronic Heart Failure Treatment Growth Trends by Region
2.2.1 Global Chronic Heart Failure Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Chronic Heart Failure Treatment Historic Market Size by Region (2020-2025)
2.2.3 Chronic Heart Failure Treatment Forecasted Market Size by Region (2026-2031)
2.3 Chronic Heart Failure Treatment Market Dynamics
2.3.1 Chronic Heart Failure Treatment Industry Trends
2.3.2 Chronic Heart Failure Treatment Market Drivers
2.3.3 Chronic Heart Failure Treatment Market Challenges
2.3.4 Chronic Heart Failure Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chronic Heart Failure Treatment Players by Revenue
3.1.1 Global Top Chronic Heart Failure Treatment Players by Revenue (2020-2025)
3.1.2 Global Chronic Heart Failure Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Chronic Heart Failure Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Chronic Heart Failure Treatment Revenue
3.4 Global Chronic Heart Failure Treatment Market Concentration Ratio
3.4.1 Global Chronic Heart Failure Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chronic Heart Failure Treatment Revenue in 2024
3.5 Global Key Players of Chronic Heart Failure Treatment Head office and Area Served
3.6 Global Key Players of Chronic Heart Failure Treatment, Product and Application
3.7 Global Key Players of Chronic Heart Failure Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Chronic Heart Failure Treatment Breakdown Data by Type
4.1 Global Chronic Heart Failure Treatment Historic Market Size by Type (2020-2025)
4.2 Global Chronic Heart Failure Treatment Forecasted Market Size by Type (2026-2031)
5 Chronic Heart Failure Treatment Breakdown Data by Application
5.1 Global Chronic Heart Failure Treatment Historic Market Size by Application (2020-2025)
5.2 Global Chronic Heart Failure Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Chronic Heart Failure Treatment Market Size (2020-2031)
6.2 North America Chronic Heart Failure Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Chronic Heart Failure Treatment Market Size by Country (2020-2025)
6.4 North America Chronic Heart Failure Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Chronic Heart Failure Treatment Market Size (2020-2031)
7.2 Europe Chronic Heart Failure Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Chronic Heart Failure Treatment Market Size by Country (2020-2025)
7.4 Europe Chronic Heart Failure Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Chronic Heart Failure Treatment Market Size (2020-2031)
8.2 Asia-Pacific Chronic Heart Failure Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Chronic Heart Failure Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Chronic Heart Failure Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Chronic Heart Failure Treatment Market Size (2020-2031)
9.2 Latin America Chronic Heart Failure Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Chronic Heart Failure Treatment Market Size by Country (2020-2025)
9.4 Latin America Chronic Heart Failure Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chronic Heart Failure Treatment Market Size (2020-2031)
10.2 Middle East & Africa Chronic Heart Failure Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Chronic Heart Failure Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Chronic Heart Failure Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Medtronic
11.1.1 Medtronic Company Details
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Chronic Heart Failure Treatment Introduction
11.1.4 Medtronic Revenue in Chronic Heart Failure Treatment Business (2020-2025)
11.1.5 Medtronic Recent Development
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott Chronic Heart Failure Treatment Introduction
11.2.4 Abbott Revenue in Chronic Heart Failure Treatment Business (2020-2025)
11.2.5 Abbott Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Chronic Heart Failure Treatment Introduction
11.3.4 Johnson & Johnson Revenue in Chronic Heart Failure Treatment Business (2020-2025)
11.3.5 Johnson & Johnson Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Chronic Heart Failure Treatment Introduction
11.4.4 Merck Revenue in Chronic Heart Failure Treatment Business (2020-2025)
11.4.5 Merck Recent Development
11.5 Stanley Pharmaceuticals
11.5.1 Stanley Pharmaceuticals Company Details
11.5.2 Stanley Pharmaceuticals Business Overview
11.5.3 Stanley Pharmaceuticals Chronic Heart Failure Treatment Introduction
11.5.4 Stanley Pharmaceuticals Revenue in Chronic Heart Failure Treatment Business (2020-2025)
11.5.5 Stanley Pharmaceuticals Recent Development
11.6 New Haven Pharmaceuticals, Inc.
11.6.1 New Haven Pharmaceuticals, Inc. Company Details
11.6.2 New Haven Pharmaceuticals, Inc. Business Overview
11.6.3 New Haven Pharmaceuticals, Inc. Chronic Heart Failure Treatment Introduction
11.6.4 New Haven Pharmaceuticals, Inc. Revenue in Chronic Heart Failure Treatment Business (2020-2025)
11.6.5 New Haven Pharmaceuticals, Inc. Recent Development
11.7 Boston Scientific Corporation
11.7.1 Boston Scientific Corporation Company Details
11.7.2 Boston Scientific Corporation Business Overview
11.7.3 Boston Scientific Corporation Chronic Heart Failure Treatment Introduction
11.7.4 Boston Scientific Corporation Revenue in Chronic Heart Failure Treatment Business (2020-2025)
11.7.5 Boston Scientific Corporation Recent Development
11.8 HeartWare
11.8.1 HeartWare Company Details
11.8.2 HeartWare Business Overview
11.8.3 HeartWare Chronic Heart Failure Treatment Introduction
11.8.4 HeartWare Revenue in Chronic Heart Failure Treatment Business (2020-2025)
11.8.5 HeartWare Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Chronic Heart Failure Treatment Introduction
11.9.4 Pfizer Revenue in Chronic Heart Failure Treatment Business (2020-2025)
11.9.5 Pfizer Recent Development
11.10 GlaxoSmithKline plc
11.10.1 GlaxoSmithKline plc Company Details
11.10.2 GlaxoSmithKline plc Business Overview
11.10.3 GlaxoSmithKline plc Chronic Heart Failure Treatment Introduction
11.10.4 GlaxoSmithKline plc Revenue in Chronic Heart Failure Treatment Business (2020-2025)
11.10.5 GlaxoSmithKline plc Recent Development
11.11 Novartis International AG
11.11.1 Novartis International AG Company Details
11.11.2 Novartis International AG Business Overview
11.11.3 Novartis International AG Chronic Heart Failure Treatment Introduction
11.11.4 Novartis International AG Revenue in Chronic Heart Failure Treatment Business (2020-2025)
11.11.5 Novartis International AG Recent Development
11.12 Biovail Corporation
11.12.1 Biovail Corporation Company Details
11.12.2 Biovail Corporation Business Overview
11.12.3 Biovail Corporation Chronic Heart Failure Treatment Introduction
11.12.4 Biovail Corporation Revenue in Chronic Heart Failure Treatment Business (2020-2025)
11.12.5 Biovail Corporation Recent Development
11.13 Bristol-Myers Squibb Company
11.13.1 Bristol-Myers Squibb Company Company Details
11.13.2 Bristol-Myers Squibb Company Business Overview
11.13.3 Bristol-Myers Squibb Company Chronic Heart Failure Treatment Introduction
11.13.4 Bristol-Myers Squibb Company Revenue in Chronic Heart Failure Treatment Business (2020-2025)
11.13.5 Bristol-Myers Squibb Company Recent Development
11.14 Abiomed
11.14.1 Abiomed Company Details
11.14.2 Abiomed Business Overview
11.14.3 Abiomed Chronic Heart Failure Treatment Introduction
11.14.4 Abiomed Revenue in Chronic Heart Failure Treatment Business (2020-2025)
11.14.5 Abiomed Recent Development
11.15 Symplmed Pharmaceuticals
11.15.1 Symplmed Pharmaceuticals Company Details
11.15.2 Symplmed Pharmaceuticals Business Overview
11.15.3 Symplmed Pharmaceuticals Chronic Heart Failure Treatment Introduction
11.15.4 Symplmed Pharmaceuticals Revenue in Chronic Heart Failure Treatment Business (2020-2025)
11.15.5 Symplmed Pharmaceuticals Recent Development
11.16 Berlin Heart GmbH
11.16.1 Berlin Heart GmbH Company Details
11.16.2 Berlin Heart GmbH Business Overview
11.16.3 Berlin Heart GmbH Chronic Heart Failure Treatment Introduction
11.16.4 Berlin Heart GmbH Revenue in Chronic Heart Failure Treatment Business (2020-2025)
11.16.5 Berlin Heart GmbH Recent Development
11.17 ReliantHeart, Inc.
11.17.1 ReliantHeart, Inc. Company Details
11.17.2 ReliantHeart, Inc. Business Overview
11.17.3 ReliantHeart, Inc. Chronic Heart Failure Treatment Introduction
11.17.4 ReliantHeart, Inc. Revenue in Chronic Heart Failure Treatment Business (2020-2025)
11.17.5 ReliantHeart, Inc. Recent Development
11.18 Cardiokinetix
11.18.1 Cardiokinetix Company Details
11.18.2 Cardiokinetix Business Overview
11.18.3 Cardiokinetix Chronic Heart Failure Treatment Introduction
11.18.4 Cardiokinetix Revenue in Chronic Heart Failure Treatment Business (2020-2025)
11.18.5 Cardiokinetix Recent Development
11.19 Biotronik
11.19.1 Biotronik Company Details
11.19.2 Biotronik Business Overview
11.19.3 Biotronik Chronic Heart Failure Treatment Introduction
11.19.4 Biotronik Revenue in Chronic Heart Failure Treatment Business (2020-2025)
11.19.5 Biotronik Recent Development
11.20 Jarvik Heart
11.20.1 Jarvik Heart Company Details
11.20.2 Jarvik Heart Business Overview
11.20.3 Jarvik Heart Chronic Heart Failure Treatment Introduction
11.20.4 Jarvik Heart Revenue in Chronic Heart Failure Treatment Business (2020-2025)
11.20.5 Jarvik Heart Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Medtronic Inc
Abbott
Johnson & Johnson
Merck
Stanley Pharmaceuticals
New Haven Pharmaceuticals, Inc.
Boston Scientific Corporation
HeartWare
Pfizer Inc
GlaxoSmithKline PLC
Novartis International AG
Biovail Corporation
Bristol Myers Squibb Company
Abiomed Inc
Symplmed Pharmaceuticals
Berlin Heart GmbH
ReliantHeart Inc
Cardiokinetix
Biotronik AG
Jarvik Heart
List of Tables
 Table 1. Global Chronic Heart Failure Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of ICDs
 Table 3. Key Players of VADs
 Table 4. Key Players of Drugs
 Table 5. Key Players of Others
 Table 6. Global Chronic Heart Failure Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Chronic Heart Failure Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Chronic Heart Failure Treatment Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Chronic Heart Failure Treatment Market Share by Region (2020-2025)
 Table 10. Global Chronic Heart Failure Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Chronic Heart Failure Treatment Market Share by Region (2026-2031)
 Table 12. Chronic Heart Failure Treatment Market Trends
 Table 13. Chronic Heart Failure Treatment Market Drivers
 Table 14. Chronic Heart Failure Treatment Market Challenges
 Table 15. Chronic Heart Failure Treatment Market Restraints
 Table 16. Global Chronic Heart Failure Treatment Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Chronic Heart Failure Treatment Market Share by Players (2020-2025)
 Table 18. Global Top Chronic Heart Failure Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Heart Failure Treatment as of 2024)
 Table 19. Ranking of Global Top Chronic Heart Failure Treatment Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Chronic Heart Failure Treatment Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Chronic Heart Failure Treatment, Headquarters and Area Served
 Table 22. Global Key Players of Chronic Heart Failure Treatment, Product and Application
 Table 23. Global Key Players of Chronic Heart Failure Treatment, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Chronic Heart Failure Treatment Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Chronic Heart Failure Treatment Revenue Market Share by Type (2020-2025)
 Table 27. Global Chronic Heart Failure Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Chronic Heart Failure Treatment Revenue Market Share by Type (2026-2031)
 Table 29. Global Chronic Heart Failure Treatment Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Chronic Heart Failure Treatment Revenue Market Share by Application (2020-2025)
 Table 31. Global Chronic Heart Failure Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Chronic Heart Failure Treatment Revenue Market Share by Application (2026-2031)
 Table 33. North America Chronic Heart Failure Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Chronic Heart Failure Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Chronic Heart Failure Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Chronic Heart Failure Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Chronic Heart Failure Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Chronic Heart Failure Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Chronic Heart Failure Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Chronic Heart Failure Treatment Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Chronic Heart Failure Treatment Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Chronic Heart Failure Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Chronic Heart Failure Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Chronic Heart Failure Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Chronic Heart Failure Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Chronic Heart Failure Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Chronic Heart Failure Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Medtronic Company Details
 Table 49. Medtronic Business Overview
 Table 50. Medtronic Chronic Heart Failure Treatment Product
 Table 51. Medtronic Revenue in Chronic Heart Failure Treatment Business (2020-2025) & (US$ Million)
 Table 52. Medtronic Recent Development
 Table 53. Abbott Company Details
 Table 54. Abbott Business Overview
 Table 55. Abbott Chronic Heart Failure Treatment Product
 Table 56. Abbott Revenue in Chronic Heart Failure Treatment Business (2020-2025) & (US$ Million)
 Table 57. Abbott Recent Development
 Table 58. Johnson & Johnson Company Details
 Table 59. Johnson & Johnson Business Overview
 Table 60. Johnson & Johnson Chronic Heart Failure Treatment Product
 Table 61. Johnson & Johnson Revenue in Chronic Heart Failure Treatment Business (2020-2025) & (US$ Million)
 Table 62. Johnson & Johnson Recent Development
 Table 63. Merck Company Details
 Table 64. Merck Business Overview
 Table 65. Merck Chronic Heart Failure Treatment Product
 Table 66. Merck Revenue in Chronic Heart Failure Treatment Business (2020-2025) & (US$ Million)
 Table 67. Merck Recent Development
 Table 68. Stanley Pharmaceuticals Company Details
 Table 69. Stanley Pharmaceuticals Business Overview
 Table 70. Stanley Pharmaceuticals Chronic Heart Failure Treatment Product
 Table 71. Stanley Pharmaceuticals Revenue in Chronic Heart Failure Treatment Business (2020-2025) & (US$ Million)
 Table 72. Stanley Pharmaceuticals Recent Development
 Table 73. New Haven Pharmaceuticals, Inc. Company Details
 Table 74. New Haven Pharmaceuticals, Inc. Business Overview
 Table 75. New Haven Pharmaceuticals, Inc. Chronic Heart Failure Treatment Product
 Table 76. New Haven Pharmaceuticals, Inc. Revenue in Chronic Heart Failure Treatment Business (2020-2025) & (US$ Million)
 Table 77. New Haven Pharmaceuticals, Inc. Recent Development
 Table 78. Boston Scientific Corporation Company Details
 Table 79. Boston Scientific Corporation Business Overview
 Table 80. Boston Scientific Corporation Chronic Heart Failure Treatment Product
 Table 81. Boston Scientific Corporation Revenue in Chronic Heart Failure Treatment Business (2020-2025) & (US$ Million)
 Table 82. Boston Scientific Corporation Recent Development
 Table 83. HeartWare Company Details
 Table 84. HeartWare Business Overview
 Table 85. HeartWare Chronic Heart Failure Treatment Product
 Table 86. HeartWare Revenue in Chronic Heart Failure Treatment Business (2020-2025) & (US$ Million)
 Table 87. HeartWare Recent Development
 Table 88. Pfizer Company Details
 Table 89. Pfizer Business Overview
 Table 90. Pfizer Chronic Heart Failure Treatment Product
 Table 91. Pfizer Revenue in Chronic Heart Failure Treatment Business (2020-2025) & (US$ Million)
 Table 92. Pfizer Recent Development
 Table 93. GlaxoSmithKline plc Company Details
 Table 94. GlaxoSmithKline plc Business Overview
 Table 95. GlaxoSmithKline plc Chronic Heart Failure Treatment Product
 Table 96. GlaxoSmithKline plc Revenue in Chronic Heart Failure Treatment Business (2020-2025) & (US$ Million)
 Table 97. GlaxoSmithKline plc Recent Development
 Table 98. Novartis International AG Company Details
 Table 99. Novartis International AG Business Overview
 Table 100. Novartis International AG Chronic Heart Failure Treatment Product
 Table 101. Novartis International AG Revenue in Chronic Heart Failure Treatment Business (2020-2025) & (US$ Million)
 Table 102. Novartis International AG Recent Development
 Table 103. Biovail Corporation Company Details
 Table 104. Biovail Corporation Business Overview
 Table 105. Biovail Corporation Chronic Heart Failure Treatment Product
 Table 106. Biovail Corporation Revenue in Chronic Heart Failure Treatment Business (2020-2025) & (US$ Million)
 Table 107. Biovail Corporation Recent Development
 Table 108. Bristol-Myers Squibb Company Company Details
 Table 109. Bristol-Myers Squibb Company Business Overview
 Table 110. Bristol-Myers Squibb Company Chronic Heart Failure Treatment Product
 Table 111. Bristol-Myers Squibb Company Revenue in Chronic Heart Failure Treatment Business (2020-2025) & (US$ Million)
 Table 112. Bristol-Myers Squibb Company Recent Development
 Table 113. Abiomed Company Details
 Table 114. Abiomed Business Overview
 Table 115. Abiomed Chronic Heart Failure Treatment Product
 Table 116. Abiomed Revenue in Chronic Heart Failure Treatment Business (2020-2025) & (US$ Million)
 Table 117. Abiomed Recent Development
 Table 118. Symplmed Pharmaceuticals Company Details
 Table 119. Symplmed Pharmaceuticals Business Overview
 Table 120. Symplmed Pharmaceuticals Chronic Heart Failure Treatment Product
 Table 121. Symplmed Pharmaceuticals Revenue in Chronic Heart Failure Treatment Business (2020-2025) & (US$ Million)
 Table 122. Symplmed Pharmaceuticals Recent Development
 Table 123. Berlin Heart GmbH Company Details
 Table 124. Berlin Heart GmbH Business Overview
 Table 125. Berlin Heart GmbH Chronic Heart Failure Treatment Product
 Table 126. Berlin Heart GmbH Revenue in Chronic Heart Failure Treatment Business (2020-2025) & (US$ Million)
 Table 127. Berlin Heart GmbH Recent Development
 Table 128. ReliantHeart, Inc. Company Details
 Table 129. ReliantHeart, Inc. Business Overview
 Table 130. ReliantHeart, Inc. Chronic Heart Failure Treatment Product
 Table 131. ReliantHeart, Inc. Revenue in Chronic Heart Failure Treatment Business (2020-2025) & (US$ Million)
 Table 132. ReliantHeart, Inc. Recent Development
 Table 133. Cardiokinetix Company Details
 Table 134. Cardiokinetix Business Overview
 Table 135. Cardiokinetix Chronic Heart Failure Treatment Product
 Table 136. Cardiokinetix Revenue in Chronic Heart Failure Treatment Business (2020-2025) & (US$ Million)
 Table 137. Cardiokinetix Recent Development
 Table 138. Biotronik Company Details
 Table 139. Biotronik Business Overview
 Table 140. Biotronik Chronic Heart Failure Treatment Product
 Table 141. Biotronik Revenue in Chronic Heart Failure Treatment Business (2020-2025) & (US$ Million)
 Table 142. Biotronik Recent Development
 Table 143. Jarvik Heart Company Details
 Table 144. Jarvik Heart Business Overview
 Table 145. Jarvik Heart Chronic Heart Failure Treatment Product
 Table 146. Jarvik Heart Revenue in Chronic Heart Failure Treatment Business (2020-2025) & (US$ Million)
 Table 147. Jarvik Heart Recent Development
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Chronic Heart Failure Treatment Picture
 Figure 2. Global Chronic Heart Failure Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Chronic Heart Failure Treatment Market Share by Type: 2024 VS 2031
 Figure 4. ICDs Features
 Figure 5. VADs Features
 Figure 6. Drugs Features
 Figure 7. Others Features
 Figure 8. Global Chronic Heart Failure Treatment Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Chronic Heart Failure Treatment Market Share by Application: 2024 VS 2031
 Figure 10. Hospital Case Studies
 Figure 11. Clinic Case Studies
 Figure 12. Household Case Studies
 Figure 13. Others Case Studies
 Figure 14. Chronic Heart Failure Treatment Report Years Considered
 Figure 15. Global Chronic Heart Failure Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global Chronic Heart Failure Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Chronic Heart Failure Treatment Market Share by Region: 2024 VS 2031
 Figure 18. Global Chronic Heart Failure Treatment Market Share by Players in 2024
 Figure 19. Global Top Chronic Heart Failure Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Heart Failure Treatment as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by Chronic Heart Failure Treatment Revenue in 2024
 Figure 21. North America Chronic Heart Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America Chronic Heart Failure Treatment Market Share by Country (2020-2031)
 Figure 23. United States Chronic Heart Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada Chronic Heart Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Chronic Heart Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Chronic Heart Failure Treatment Market Share by Country (2020-2031)
 Figure 27. Germany Chronic Heart Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France Chronic Heart Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. Chronic Heart Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy Chronic Heart Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia Chronic Heart Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries Chronic Heart Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Chronic Heart Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Chronic Heart Failure Treatment Market Share by Region (2020-2031)
 Figure 35. China Chronic Heart Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan Chronic Heart Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea Chronic Heart Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia Chronic Heart Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India Chronic Heart Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia Chronic Heart Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Chronic Heart Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Chronic Heart Failure Treatment Market Share by Country (2020-2031)
 Figure 43. Mexico Chronic Heart Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil Chronic Heart Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Chronic Heart Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Chronic Heart Failure Treatment Market Share by Country (2020-2031)
 Figure 47. Turkey Chronic Heart Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Chronic Heart Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE Chronic Heart Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Medtronic Revenue Growth Rate in Chronic Heart Failure Treatment Business (2020-2025)
 Figure 51. Abbott Revenue Growth Rate in Chronic Heart Failure Treatment Business (2020-2025)
 Figure 52. Johnson & Johnson Revenue Growth Rate in Chronic Heart Failure Treatment Business (2020-2025)
 Figure 53. Merck Revenue Growth Rate in Chronic Heart Failure Treatment Business (2020-2025)
 Figure 54. Stanley Pharmaceuticals Revenue Growth Rate in Chronic Heart Failure Treatment Business (2020-2025)
 Figure 55. New Haven Pharmaceuticals, Inc. Revenue Growth Rate in Chronic Heart Failure Treatment Business (2020-2025)
 Figure 56. Boston Scientific Corporation Revenue Growth Rate in Chronic Heart Failure Treatment Business (2020-2025)
 Figure 57. HeartWare Revenue Growth Rate in Chronic Heart Failure Treatment Business (2020-2025)
 Figure 58. Pfizer Revenue Growth Rate in Chronic Heart Failure Treatment Business (2020-2025)
 Figure 59. GlaxoSmithKline plc Revenue Growth Rate in Chronic Heart Failure Treatment Business (2020-2025)
 Figure 60. Novartis International AG Revenue Growth Rate in Chronic Heart Failure Treatment Business (2020-2025)
 Figure 61. Biovail Corporation Revenue Growth Rate in Chronic Heart Failure Treatment Business (2020-2025)
 Figure 62. Bristol-Myers Squibb Company Revenue Growth Rate in Chronic Heart Failure Treatment Business (2020-2025)
 Figure 63. Abiomed Revenue Growth Rate in Chronic Heart Failure Treatment Business (2020-2025)
 Figure 64. Symplmed Pharmaceuticals Revenue Growth Rate in Chronic Heart Failure Treatment Business (2020-2025)
 Figure 65. Berlin Heart GmbH Revenue Growth Rate in Chronic Heart Failure Treatment Business (2020-2025)
 Figure 66. ReliantHeart, Inc. Revenue Growth Rate in Chronic Heart Failure Treatment Business (2020-2025)
 Figure 67. Cardiokinetix Revenue Growth Rate in Chronic Heart Failure Treatment Business (2020-2025)
 Figure 68. Biotronik Revenue Growth Rate in Chronic Heart Failure Treatment Business (2020-2025)
 Figure 69. Jarvik Heart Revenue Growth Rate in Chronic Heart Failure Treatment Business (2020-2025)
 Figure 70. Bottom-up and Top-down Approaches for This Report
 Figure 71. Data Triangulation
 Figure 72. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Chronic Heart Failure CHF Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Congestive Heart Failure Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hypertension and Heart Failure Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cardiovascular Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cardiac Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Restrictive Cardiomyopathy Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cardiovascular Drug Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Chronic Pain Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Rheumatic Heart Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cardiovascular Therapeutic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cardiovascular Disease Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Left Ventricular Dysfunction Drug Market Research Report 2025
Heart and Lung Therapy System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Ischemic Cardiomyopathy Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Myocarditis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Structural Heart Products Market Research Report 2024
Cardiac Resynchronization Therapy Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Chronic Metabolic Disease Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Chronic Kidney Disease Drugs Market Research Report 2025
Ventricular Fibrillation Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Low-Density Lipoprotein Cholesterol Assay Kit Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32E19705
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Cardiovascular Informations (CVIS) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10A6248
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Pulmonary Arterial Hypertension (PAH) Medicine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8I7059
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Heparin Calcium Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15Y8668
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions